Clinical Trial Update: Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of Z-208 in advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Z-208

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Advanced Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED